SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Sio Gene Therapies Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 08:53 am Sale | 2022-12-31 | 13G | Sio Gene Therapies Inc. SIOX | SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% | -5,914,000 (Position Closed) | Filing |
| 2022-02-11 4:45 pm Purchase | 2021-12-31 | 13G | Sio Gene Therapies Inc. SIOX | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 8.100% | 425,000 (+7.74%) | Filing |
| 2021-02-26 4:24 pm Purchase | 2021-02-17 | 13G | Sio Gene Therapies Inc. SIOX | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 8.600% | 5,489,000 (New Position) | Filing |